Apthera IOL

Directions Website Contact the business

Apthera IOL IC-8 Apthera is the first approved small aperture IOL designed to provide extended depth of focus Welcome to the IC-8โ„ข Aptheraโ„ข U.S.

page from Bausch + Lomb Surgical. IC-8 Apthera is the first approved small aperture IOL designed to provide extended depth of focus. https://www.bausch.com/terms
โ€ข Bausch + Lomb Surgical products are intended for eye care professionals and veterinary professionals use only.
โ€ข For a list of product indications, precautions, contraindication and warnings, please click here: https://www.bauschsurgical.com/safety/ -apthera
โ€ข If you are a patient, please consult with your doctor to see if Apthera is right for you. COMMUNITY GUIDELINES
When posting photos, questions, or comments, please respect our guidelines as outlined below, which apply to all U.S. Bausch + Lomb social media channels. Please also note that we reserve the right to remove posts or comments that we determine in our sole discretion to be:
(a) Abusive, defamatory, or obscene;
(b) Fraudulent, deceptive, or misleading;
(c) In violation of any intellectual property right of another;
(d) In violation of any law or regulation, or
(e) Otherwise offensive, graphically or in tone;
(f) Disparaging of third-party products;
(g) Mentions a Bausch + Lomb prescription product by name with a claim of efficacy;
(h) Mentions a side effect of a product. Further, we may contact you for more information. If you wish to contact the FDA directly about a side effect, you can visit www.fda.gov/medwatch or call 1-800-FDA-1088;
(i) Medical advice;
(j) Clearly off-topic or constitutes spam. Any product complaint should be reported to Bausch + Lomb Customer Care at 1-800-553-5340 or [email protected]. Since our social media channels are intended for respectful and productive discourse, anyone repeatedly posting material that falls into the above categories will not be allowed to further engage with those social channels. These users will also be blocked from engaging with those pages, where available. These community guidelines are for Bausch + Lomb social media channels in the United States. Please note that our social media channels are in English only. Please note that Bausch + Lomb does not necessarily endorse, nor is responsible for, the accuracy of information, opinions, claims, or advice shared by followers or commenters of Bausch + Lombโ€™s social channels. For any questions about Bausch + Lomb or its product, please call 1-800-553-5340.

12/22/2025

"๐—š๐—ถ๐˜ƒ๐—ฒ ๐—ฃ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜๐˜€ ๐—ฎ ๐—Ÿ๐—ถ๐—ณ๐—ฒ๐˜๐—ถ๐—บ๐—ฒ ๐—ผ๐—ณ ๐—•๐—ฒ๐—ป๐—ฒ๐—ณ๐—ถ๐˜"
Hear Dr. Eric Donnenfeld, MD talk about how implanting enVista Envyโ„ข IOLs is always the exciting part of his day and how the reports of low visual disturbances by patients post-op could be the nudge some ophthalmologists need to confidently evaluate full range of vision IOLs for patients.

Learn More: https://bit.ly/4hlHf6F

For indications and important safety information, visit: https://bit.ly/4nKCrK8

๐—ฃ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜ ๐—ฃ๐—ฒ๐—ฟ๐˜€๐—ฝ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ๐˜€: ๐—ฒ๐—ป๐—ฉ๐—ถ๐˜€๐˜๐—ฎ ๐—˜๐—ป๐˜ƒ๐˜†โ„ข "๐—œ ๐—ฐ๐—ผ๐˜‚๐—น๐—ฑ ๐˜€๐—ฒ๐—ฒ ๐—ฝ๐—ฟ๐—ฒ๐˜๐˜๐˜† ๐—ฐ๐—น๐—ฒ๐—ฎ๐—ฟ๐—น๐˜† ๐—ฟ๐—ถ๐—ด๐—ต๐˜ ๐—ฎ๐˜„๐—ฎ๐˜†"Following implantation of enVista Envyโ„ข IOLs,...
12/19/2025

๐—ฃ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜ ๐—ฃ๐—ฒ๐—ฟ๐˜€๐—ฝ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ๐˜€: ๐—ฒ๐—ป๐—ฉ๐—ถ๐˜€๐˜๐—ฎ ๐—˜๐—ป๐˜ƒ๐˜†โ„ข
"๐—œ ๐—ฐ๐—ผ๐˜‚๐—น๐—ฑ ๐˜€๐—ฒ๐—ฒ ๐—ฝ๐—ฟ๐—ฒ๐˜๐˜๐˜† ๐—ฐ๐—น๐—ฒ๐—ฎ๐—ฟ๐—น๐˜† ๐—ฟ๐—ถ๐—ด๐—ต๐˜ ๐—ฎ๐˜„๐—ฎ๐˜†"
Following implantation of enVista Envyโ„ข IOLs, a recent patient reported
significant improvements in daily vision, especially when driving at night. Friends even jealously noticed she could thread a sewing needle without glasses.
โ€œ๐—œ๐˜โ€™๐˜€ ๐˜€๐—ผ ๐˜„๐—ผ๐—ฟ๐˜๐—ต ๐—ถ๐˜ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—ฒ๐—ป๐—ฑ.โ€

Individual results may vary.

Learn More: https://bit.ly/42M0ZKB

For indications and important safety information, visit: https://bit.ly/4nKCrK8

๐Ÿ“ฃ ๐— ๐—ถ๐—น๐—ฒ๐˜€๐˜๐—ผ๐—ป๐—ฒ: ๐—จ.๐—ฆ. ๐˜€๐˜‚๐—ฟ๐—ด๐—ฒ๐—ผ๐—ป๐˜€ ๐—ต๐—ฎ๐˜ƒ๐—ฒ ๐—ถ๐—บ๐—ฝ๐—น๐—ฎ๐—ป๐˜๐—ฒ๐—ฑ ๐Ÿฎ๐Ÿฑ,๐Ÿฌ๐Ÿฌ๐Ÿฌ+ ๐—ฒ๐—ป๐—ฉ๐—ถ๐˜€๐˜๐—ฎ ๐—˜๐—ป๐˜ƒ๐˜†โ„ข ๐—œ๐—ข๐—Ÿ๐˜€.Bausch + Lomb is proud to partner with forward-thin...
12/16/2025

๐Ÿ“ฃ ๐— ๐—ถ๐—น๐—ฒ๐˜€๐˜๐—ผ๐—ป๐—ฒ: ๐—จ.๐—ฆ. ๐˜€๐˜‚๐—ฟ๐—ด๐—ฒ๐—ผ๐—ป๐˜€ ๐—ต๐—ฎ๐˜ƒ๐—ฒ ๐—ถ๐—บ๐—ฝ๐—น๐—ฎ๐—ป๐˜๐—ฒ๐—ฑ ๐Ÿฎ๐Ÿฑ,๐Ÿฌ๐Ÿฌ๐Ÿฌ+ ๐—ฒ๐—ป๐—ฉ๐—ถ๐˜€๐˜๐—ฎ ๐—˜๐—ป๐˜ƒ๐˜†โ„ข ๐—œ๐—ข๐—Ÿ๐˜€.

Bausch + Lomb is proud to partner with forward-thinking surgeons across the U.S. who are committed to innovations which support patient needs, empowering them to ๐—™๐—น๐—ผ๐˜‚๐—ฟ๐—ถ๐˜€๐—ต ๐—”๐˜ ๐—˜๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ฆ๐˜๐—ฒ๐—ฝ. ๐Ÿฆš

Connect with your B+L representative to learn more.

12/08/2025

"๐—ข๐—ป๐—ฒ ๐—ผ๐—ณ ๐˜๐—ต๐—ฒ ๐—˜๐—ฎ๐˜€๐—ถ๐—ฒ๐˜€๐˜ ๐—Ÿ๐—ฒ๐—ป๐˜€๐—ฒ๐˜€ ๐˜๐—ผ ๐—š๐—ฒ๐˜ ๐—œ๐—ป๐˜๐—ผ ๐˜๐—ต๐—ฒ ๐—˜๐˜†๐—ฒ"
Hear Dr. Lisa Feulner, MD, PhD discuss the simplicity of the enVista Envyโ„ข and how the range of toric treatment options enables her to reduce the astigmatism as much as possible, setting it apart from other presbyopia-correcting IOLs.

Learn More: https://bit.ly/4hlHf6F

For indications and important safety information, visit: https://bit.ly/4nKCrK8

11/25/2025

"๐—ฃ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜ ๐—ฆ๐—ฎ๐˜๐—ถ๐˜€๐—ณ๐—ฎ๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐—ถ๐˜€ ๐—ช๐—ต๐—ฎ๐˜ ๐—œ๐˜'๐˜€ ๐—”๐—น๐—น ๐—”๐—ฏ๐—ผ๐˜‚๐˜"
Hear Dr. Paul Singh, MD discuss how enVista Envyโ„ข has allowed him to achieve patients that are "20 Happy" and address their expectations for distance vision, low-light contrast vision, and functional near vision for a confident full range of vision.

Learn More: https://bit.ly/4hlHf6F

For indications and important safety information, visit: https://bit.ly/4nKCrK8

๐—ฃ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜ ๐—ฃ๐—ฒ๐—ฟ๐˜€๐—ฝ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ๐˜€: ๐—ฒ๐—ป๐—ฉ๐—ถ๐˜€๐˜๐—ฎ ๐—˜๐—ป๐˜ƒ๐˜†โ„ข "๐—œ๐˜'๐˜€ ๐—ฏ๐—ฒ๐—ฒ๐—ป ๐—ฎ ๐˜„๐—ผ๐—ป๐—ฑ๐—ฒ๐—ฟ๐—ณ๐˜‚๐—น ๐—ฒ๐˜…๐—ฝ๐—ฒ๐—ฟ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ."Following implantation of enVista Envyโ„ข IOLs, a r...
11/19/2025

๐—ฃ๐—ฎ๐˜๐—ถ๐—ฒ๐—ป๐˜ ๐—ฃ๐—ฒ๐—ฟ๐˜€๐—ฝ๐—ฒ๐—ฐ๐˜๐—ถ๐˜ƒ๐—ฒ๐˜€: ๐—ฒ๐—ป๐—ฉ๐—ถ๐˜€๐˜๐—ฎ ๐—˜๐—ป๐˜ƒ๐˜†โ„ข
"๐—œ๐˜'๐˜€ ๐—ฏ๐—ฒ๐—ฒ๐—ป ๐—ฎ ๐˜„๐—ผ๐—ป๐—ฑ๐—ฒ๐—ฟ๐—ณ๐˜‚๐—น ๐—ฒ๐˜…๐—ฝ๐—ฒ๐—ฟ๐—ถ๐—ฒ๐—ป๐—ฐ๐—ฒ."
Following implantation of enVista Envyโ„ข IOLs, a recent patient reported clearer vision across distances with reduced reliance on glasses for reading watching TV.

Individual results may vary.

Learn More: https://bit.ly/42M0ZKB

For indications and important safety information, visit: https://bit.ly/4nKCrK8

10/10/2025

๐Ÿ“ข ๐—ก๐—ผ๐˜„ ๐—ฃ๐˜‚๐—ฏ๐—น๐—ถ๐˜€๐—ต๐—ฒ๐—ฑ ๐—ถ๐—ป ๐˜๐—ต๐—ฒ ๐—”๐—บ๐—ฒ๐—ฟ๐—ถ๐—ฐ๐—ฎ๐—ป ๐—๐—ผ๐˜‚๐—ฟ๐—ป๐—ฎ๐—น ๐—ผ๐—ณ ๐—ข๐—ฝ๐—ต๐˜๐—ต๐—ฎ๐—น๐—บ๐—ผ๐—น๐—ผ๐—ด๐˜†
Results from the pivotal U.S. clinical trial of the enVista Envyโ„ข are in and confirms the full range of vision IOL is a strong option for surgeons committed to advancing outcomes in cataract care.

๐Ÿ”น Met all primary efficacy & safety endpoints in a multicenter study
๐Ÿ”น Delivered excellent visual performance & contrast sensitivity
๐Ÿ”น Showed a favorable dysphotopsia profile
๐Ÿ”น Demonstrated consistent visual acuity of ~0.1 logMAR from -1.50 to -2.50D

โ€œTrial results mirror what I have seen in my practiceโ€ฆ I will continue to rely on enVista Envyโ„ข as an excellent option for cataract patients seeking a full range of vision with minimal visual disturbances, as well as precision astigmatism correction.โ€
โ€” Dr. Mitchell Shultz, lead author

๐Ÿ”— https://loom.ly/nFgkD-Q

10/08/2025

๐Ÿชท ๐—›๐—ฎ๐—ฟ๐—ป๐—ฒ๐˜€๐˜€ ๐˜๐—ต๐—ฒ ๐—ฃ๐—ผ๐˜„๐—ฒ๐—ฟ ๐—ผ๐—ณ ๐—™๐—ผ๐—ฐ๐˜‚๐˜€๐—ฒ๐—ฑ ๐—Ÿ๐—ถ๐—ด๐—ต๐˜
๐—ฆ๐˜„๐—ถ๐—ฝ๐—ฒ ๐˜๐—ต๐—ฟ๐—ผ๐˜‚๐—ด๐—ต ๐˜๐—ผ ๐˜€๐—ฒ๐—ฒ ๐—ต๐—ผ๐˜„ ๐˜๐—ต๐—ฒ ๐—œ๐—–-๐Ÿดยฎ ๐—”๐—ฝ๐˜๐—ต๐—ฒ๐—ฟ๐—ฎโ„ข ๐—œ๐—ข๐—Ÿ can help deliver:

โœ… Continuous range of vision with reduced blurry zones
โœ… Enhanced retinal image quality through selective light filtering
โœ… Reliable monofocal-like distance vision, plus improved intermediate and near focus

Support your patientsโ€™ visual goals with precision and confidence.

๐Ÿ”—: https://www.bauschsurgical.com/cataract/ic-8-apthera-iol

09/29/2025

๐—ฒ๐—ป๐—ฉ๐—ถ๐˜€๐˜๐—ฎ ๐—˜๐—ป๐˜ƒ๐˜†โ„ข - ๐—˜๐˜…๐—ฐ๐—ฒ๐—ฝ๐˜๐—ถ๐—ผ๐—ป๐—ฎ๐—น ๐˜ƒ๐—ถ๐˜€๐—ถ๐—ผ๐—ป ๐—ฎ๐˜ ๐—ฒ๐˜ƒ๐—ฒ๐—ฟ๐˜† ๐—ฑ๐—ถ๐˜€๐˜๐—ฎ๐—ป๐—ฐ๐—ฒ. ๐Ÿ‘

Experience outstanding visual acuity with enVista Envyโ„ข, delivering excellent results across near, intermediate, and distance vision.

Elevate your expectations, learn more at www.bauschsurgical.com/cataract/enVista-Envy/

For safety information, visit https://www.bauschsurgical.com/safety/ -envy

Address

400 Somerset Corporate Boulevard
Bridgewater, NJ
08807

Alerts

Be the first to know and let us send you an email when Apthera IOL posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Apthera IOL:

Shortcuts

Share

Category